PCN18 Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Effectiveness and Patient-Reported Outcomes Multicohort Study
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.110
https://www.valueinhealthjournal.com/article/S1098-3015(21)00327-2/fulltext
Title :
PCN18 Cetuximab Versus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Effectiveness and Patient-Reported Outcomes Multicohort Study
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00327-2&doi=10.1016/j.jval.2021.04.110
First page :
Section Title :
Open access? :
No
Section Order :
10547